FDS Stock Factset Research Systems (FDS, $441.43) price moved above its 50-day Moving Average on June 27, 2025

GET DAILY SIGNALS

Get AI intraday signals

FDS - Factset Research Systems

Moving Avg. signal

View

Odds of UP Trend

Price: $441.43

Daily change: +$4.4 (+1.01%)

Daily volume: 662K

Capitalization: $16.8B

Industry: Investment Banks/Brokers

FDS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for FDS turned positive on June 24, 2025. Looking at past instances where FDS's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FDS's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 23, 2025. You may want to consider a long position or call options on FDS as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

FDS moved above its 50-day moving average on June 27, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FDS crossed bullishly above the 50-day moving average on July 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FDS advanced for three days, in of 374 cases, the price rose further within the following month. The odds of a continued upward trend are .

FDS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FDS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for FDS entered a downward trend on June 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FDS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.921) is normal, around the industry mean (5.755). P/E Ratio (35.832) is within average values for comparable stocks, (35.318). Projected Growth (PEG Ratio) (2.368) is also within normal values, averaging (2.610). Dividend Yield (0.009) settles around the average of (0.031) among similar stocks. P/S Ratio (8.104) is also within normal values, averaging (82.424).